Russell Investments Group
VMD icon

Russell Investments Group’s Viemed Healthcare VMD Stock Holding History

Russell Investments Group’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
25,030
+22,112
+758% +$219K ﹤0.01% 3037
2026
Q1 		$26.9K Sell
2,918
-7,385
-72% -$61.5K ﹤0.01% 3524
2025
Q4 		$76.5K Sell
10,303
-208,568
-95% -$1.43M ﹤0.01% 3152
2025
Q3 		$1.49M Buy
218,871
+13,031
+6% +$88.2K ﹤0.01% 2014
2025
Q2 		$1.42M Buy
205,840
+5,051
+3% +$34.3K ﹤0.01% 1893
2025
Q1 		$1.46M Buy
200,789
+28,584
+17% +$224K ﹤0.01% 1862
2024
Q4 		$1.38M Buy
172,205
+13,589
+9% +$118K ﹤0.01% 1848
2024
Q3 		$1.16M Buy
158,616
+6,412
+4% +$45.8K ﹤0.01% 1961
2024
Q2 		$997K Buy
152,204
+5,252
+4% +$39.6K ﹤0.01% 1980
2024
Q1 		$1.39M Buy
146,952
+7,386
+5% +$63.3K ﹤0.01% 1837
2023
Q4 		$1.1M Sell
139,566
-3,393
-2% -$24.6K ﹤0.01% 1920
2023
Q3 		$962K Buy
142,959
+13,986
+11% +$115K ﹤0.01% 1949
2023
Q2 		$1.26M Sell
128,973
-24,112
-16% -$245K ﹤0.01% 1811
2023
Q1 		$1.48M Sell
153,085
-4,289
-3% -$37.4K ﹤0.01% 1758
2022
Q4 		$1.19M Buy
+157,374
New +$1.07M ﹤0.01% 1881
2022
Q1 		– Sell
-616,725
Closed -$3.22M – 2939
2021
Q4 		$3.22M Buy
616,725
+169,263
+38% +$945K 0.01% 1526
2021
Q3 		$2.48M Buy
447,462
+253,097
+130% +$1.65M ﹤0.01% 1706
2021
Q2 		$1.39M Sell
194,365
-32,991
-15% -$286K ﹤0.01% 2148
2021
Q1 		$2.3M Buy
227,356
+101,156
+80% +$952K ﹤0.01% 1800
2020
Q4 		$979K Buy
126,200
+55,700
+79% +$490K ﹤0.01% 2123
2020
Q3 		$609K Sell
70,500
-24,500
-26% -$247K ﹤0.01% 2305
2020
Q2 		$912K Buy
+95,000
New +$739K ﹤0.01% 2110
2019
Q4 		– Sell
-24,083
Closed -$167K – 3141
2019
Q3 		$167K Buy
+24,083
New +$160K ﹤0.01% 2668

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Russell Investments Group's VMD Position: Q2 2026 in Review

Russell Investments Group increased its Viemed Healthcare (VMD) stake by 758% in Q2 2026, buying an estimated $219K and bringing the position to 25,030 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3037.

Russell Investments Group first reported a position in VMD in Q3 2019 and has held it in 23 quarters since. The position peaked at $3.22M in Q4 2021. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Russell Investments Group held 25,030 shares of Viemed Healthcare worth $285K as of Q2 2026.
  • Russell Investments Group bought 22,112 Viemed Healthcare shares in Q2 2026, an estimated $219K.
  • Viemed Healthcare made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3037 holding.
  • Russell Investments Group first reported a position in Viemed Healthcare in Q3 2019 and has held it in 23 quarters since.
  • Russell Investments Group's Viemed Healthcare position peaked at $3.22M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.